FDA Approves Amgen's Repatha® (evolocumab) To Prevent Heart Attack And Stroke
Go back to FDA Approves Amgen's Repatha® (evolocumab) To Prevent Heart Attack And Stroke| Amgen Inc (NASDAQ: AMGN) | Delayed: 432.42 -4.57 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $436.99 | 52 Week High | $176.85 | |||
| Open | $437.89 | 52 Week Low | $133.64 | |||
| Day High | $437.89 | P/E | 65.12 | |||
| Day Low | $430.72 | EPS | $6.64 | |||
| Volume | 1,739,931 | |||||
